Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Operating Margin (2019 - 2023)

Historic Operating Margin for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to 249.42%.

  • ADC Therapeutics' Operating Margin fell 2453400.0% to 249.42% in Q3 2023 from the same period last year, while for Sep 2023 it was 15.56%, marking a year-over-year increase of 650500.0%. This contributed to the annual value of 2.36% for FY2022, which is 7740100.0% up from last year.
  • ADC Therapeutics' Operating Margin amounted to 249.42% in Q3 2023, which was down 2453400.0% from 205.62% recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Operating Margin registered a high of 0.03% during Q1 2020, and its lowest value of 16095.5% during Q4 2019.
  • Its 5-year average for Operating Margin is 1570.57%, with a median of 271.55% in 2023.
  • Per our database at Business Quant, ADC Therapeutics' Operating Margin skyrocketed by 22557500bps in 2020 and then plummeted by -4034300bps in 2021.
  • ADC Therapeutics' Operating Margin (Quarter) stood at 16095.5% in 2019, then skyrocketed by 100bps to 36.16% in 2020, then crashed by -921bps to 369.08% in 2021, then soared by 96bps to 15.38% in 2022, then tumbled by -1521bps to 249.42% in 2023.
  • Its Operating Margin was 249.42% in Q3 2023, compared to 205.62% in Q2 2023 and 271.55% in Q1 2023.